Search filters

List of works by Dirk J. Kwekkeboom

(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives

scientific article

A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management

scientific article published on 31 August 2016

Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).

scientific article

Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate

scientific article published on 27 February 2009

Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?

scientific article published on 18 July 2006

Comparison of response evaluation in patients with gastroenteropancreatic and thoracic neuroendocrine tumors after treatment with [177Lu-DOTA0,Tyr3]octreotate

scientific article published in October 2013

Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary

scientific article

Consensus on biomarkers for neuroendocrine tumour disease

scientific article published on September 2015

Diagnostic imaging of dopamine receptors in pituitary adenomas

scientific article published on April 2007

Diffuse Lung and Stomach Uptake of Tc-99m Oxidronate (HDP) ⬇️

scientific article published on October 1, 2003

Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging?

scientific article published in November 2006

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

article

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging

scientific article published on 30 March 2017

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs

scientific article published on 28 August 2009

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide

scientific article published on 28 August 2009

ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms

scientific article published on 15 February 2012

ENETS consensus guidelines for the management of peritoneal carcinomatosis from neuroendocrine tumors

scientific article published on 29 April 2010

Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine function

scientific article published on 27 May 2009

Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma

scientific article published on 01 October 2006

Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy

scientific article

GEPNETs update: Radionuclide therapy in neuroendocrine tumors

scientific article published on 12 August 2014

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.

scientific article published on 16 January 2008

Hypocalcaemia after treatment with [177Lu-DOTA 0,Tyr3]octreotate

scientific article published on 23 July 2013

Improved Control of Severe Hypoglycemia in Patients with Malignant Insulinomas by Peptide Receptor Radionuclide Therapy ⬇️

scientific article published on September 14, 2011

In vivo and in vitro detection of dopamine d2 receptors in uveal melanomas

scientific article published on December 2003

Increased Mammary Uptake on 111In Pentetreotide Scintigraphy ⬇️

scientific article published on 01 August 2012

Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?

scientific article published on 01 October 2006

Is There an Additional Value of Using Somatostatin Receptor Subtype 2a Immunohistochemistry Compared to Somatostatin Receptor Scintigraphy Uptake in Predicting Gastroenteropancreatic Neuroendocrine Tumor Response?

scientific article published on 05 November 2015

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors.

scientific article

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate

scientific article published in January 2005

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors

scientific article published on 2 October 2014

Lutetium-labelled peptides for therapy of neuroendocrine tumours ⬇️

scientific article published on February 1, 2012

Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy

scientific article published on 01 January 2005

Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors.

scientific article

Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels

scientific article

Neoadjuvant Treatment of Nonfunctioning Pancreatic Neuroendocrine Tumors with [177Lu-DOTA0,Tyr3]Octreotate

scientific article published on 13 August 2015

Neoadjuvant downsizing by internal radiation: a case for preoperative peptide receptor radionuclide therapy in patients with pancreatic neuroendocrine tumors.

scientific article

Nephrotoxicity after PRRT with (177)Lu-DOTA-octreotate

scientific article published on 10 May 2016

Neuroendocrine Tumors

Neuroendocrine tumors. Peptide receptor radionuclide therapy

scientific article published on March 2007

Neuroendocrine tumours: the role of imaging for diagnosis and therapy

scientific article published on 10 December 2013

New therapeutic options for metastatic malignant insulinomas ⬇️

scientific article published on September 1, 2011

Nuclear Medicine Imaging of Neuroendocrine Tumors

scientific article published on 14 August 2015

Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours

scientific article published on 17 October 2011

Octreoscan Radioreceptor Imaging ⬇️

scientific article published on April 1, 2003

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

scientific article

PRRT genomic signature in blood for prediction of 177Lu-octreotate efficacy.

scientific article published on 26 February 2018

PRRT neuroendocrine tumor response monitored using circulating transcript analysis: the NETest

scientific article published on 14 December 2019

Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up

scientific article published on 06 June 2014

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

scientific article published on January 2007

Peptide receptor imaging and therapy

scientific article

Peptide receptor radionuclide therapy

scientific article

Peptide receptor radionuclide therapy (PRRT) for GEP-NETs

scientific article published in December 2012

Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma

scientific article published in January 2005

Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors

scientific article

Peptide receptor radionuclide therapy of neuroendocrine tumours

scientific article published on 8 October 2015

Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments

scientific article published on 5 March 2014

Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin

scientific article published on 27 January 2007

Peptide-receptor radionuclide therapy for endocrine tumors

scientific article published on 02 June 2009

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.

scientific article

Physiological Uptake in the Pancreatic Head on Somatostatin Receptor Scintigraphy Using [111In-DTPA]Octreotide: Incidence and Mechanism

scientific article published on 21 October 2016

Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [177Lu-DOTA0,Tyr3]octreotate

scientific article published on 20 March 2017

Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic).

scientific article published on January 2006

Preclinical and clinical studies of peptide receptor radionuclide therapy

scientific article published on May 2010

Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.

scientific article published in December 2002

Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.

scientific article published in October 2008

Quality of Life in 265 Patients with Gastroenteropancreatic or Bronchial Neuroendocrine Tumors Treated with [177Lu-DOTA0,Tyr3]Octreotate ⬇️

scientific article published on July 27, 2011

Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate

scientific article

Radiolabeled Somatostatin Analogue Therapy Of Gastroenteropancreatic Cancer

scientific article published on May 2016

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

scientific article

Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.

scientific article

Radiopeptides for Imaging and Therapy: A Radiant Future

scientific article

Receptor imaging in the diagnosis and treatment of pituitary tumors

scientific article

Recommendations for management of patients with neuroendocrine liver metastases

scientific article published on January 2014

Refractory immune-mediated and haematological diseases: candidates for peptide receptor radiotherapy?

scientific article

Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours

scientific article

Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy

scientific article published on 13 July 2010

Safety and efficacy of everolimus in gastrointestinal and pancreatic neuroendocrine tumors after (177)Lu-octreotate.

scientific article

Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors

scientific article

Somatostatin Receptor 2-Targeting Compounds

scientific article published in September 2017

Somatostatin receptor imaging

scientific article

Somatostatin receptor imaging for neuroendocrine tumors

scientific article published on January 2006

Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors

scientific article published on March 2011

Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings

scientific article

Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors

scientific article published on 29 January 2010

Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs

scientific article

Subacute haematotoxicity after PRRT with (177)Lu-DOTA-octreotate: prognostic factors, incidence and course

scientific article published on 30 September 2015

Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors

scientific article published in April 2006

Therapy-related hematological malignancies after peptide receptor radionuclide therapy with (177)Lu-DOTA-Octreotate: Incidence, course & predicting factors in patients with GEP-NETs

scientific article published on 03 August 2017

Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy ⬇️

scientific article published on January 10, 2012

Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues

scientific article published on June 2007

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

scientific article

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

scientific article published in May 2008

Tumor Response Assessment to Treatment with [177Lu-DOTA0,Tyr3]Octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors: Differential Response of Bone Versus Soft-Tissue Lesions ⬇️

scientific article published on July 10, 2012

Tumor imaging and therapy using radiolabeled somatostatin analogues.

scientific article published in July 2009

Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas).

scientific article published on January 2006

Well-differentiated gastric tumors/carcinomas

scientific article

Well-differentiated pancreatic nonfunctioning tumors/carcinoma

scientific article published on January 2006

Well-differentiated pancreatic tumor/carcinoma: insulinoma

scientific article published on January 2006

[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas

scientific article

Paulina is supported by:

About Paulina

Help